SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

SHL Sonic Healthcare Limited

Healthcare · Diagnostics & Research · website · 47,000 employees
$18.46
52wk 18.26 – 24.27
Overall
43.0
Value
70.5
Growth
29.9
Health
48.4
Quality
37.9
Momentum
10.1
Dividend
60.2
Price
About Sonic Healthcare Limited

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Price analytics

Returns

1 day -0.8%
1 week -1.8%
1 month -4.4%
3 months -15.6%
6 months -8.3%
1 year -14.7%
3 years -37.7%

Risk

Volatility (1y ann.) 26.5%
Beta vs ASX 200 0.60
Sharpe (1y) -0.62
VaR 95% (1-day) -2.4%
Max drawdown (1y) -22.9%
Off 1-year high -22.6%

Technicals

RSI(14) 41
vs 50DMA -10.1%
vs 200DMA -11.7%
Trend Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 70.5
Trailing P/E
78
Forward P/E
78
PEG ratio
28
EV / EBITDA
57
Price / Book
96
Price / Sales
100
Growth 29.9
Revenue growth (1y)
50
Revenue CAGR (3y)
24
EPS growth (1y)
39
EPS CAGR (3y)
0
Financial Health 48.4
Net debt / EBITDA
33
Interest coverage (EBIT/interest)
74
Current ratio
11
Debt / Equity
73
Quality (Profitability & Cash Flow) 37.9
Return on equity
38
Return on assets
38
Operating margin
39
Net margin
37
Cash conversion (OCF / net income)
—
Dividend / Income 60.2
Dividend yield (%)
97
Payout ratio
40
FCF dividend cover
40
Momentum 10.1
6-month return vs ASX 200
21
Price vs 200-day average
11
Price vs 50-day average
0
Position in 52-week range
3

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$9.12B
P/E (trailing)
15.01
P/E (forward)
14.07
EPS (trailing)
1.23
Dividend yield
5.8%
Payout ratio
87.8%
Beta
0.58
EV / EBITDA
10.77
Price / Book
1.09
ROE
7.5%
Operating margin
9.7%
Net margin
5.6%
Total cash
$653.69M
Total debt
$5.84B
Current ratio
0.99
Debt / Equity
0.69
Free cash flow
$771.36M
Avg volume
2.96M
Latest annual results (FY ending 30 Jun 2025)
  • Revenue$9.62B
  • Gross profit$8.06B
  • Operating income$905.11M
  • Net income$513.60M
  • Diluted EPS1.07
  • Free cash flow$834.10M
  • Net debt$4.50B
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $84.15B — 54.3
RMD $45.86B 21.2 74.4
SIG $29.91B 43.3 55.6
FPH $21.64B 57.5 71.1
PME $16.34B 61.8 69.0
RHC $12.56B 40.0 40.2
COH $8.20B 55.5 39.4
ANN $6.27B 21.3 71.5